HomeProductsBioactive CompoundsAnti-Infective AgentsHIV ProteaseErythromycin ethyl succinate
Chemical structure of CAS 1264-62-6

Erythromycin ethyl succinate

CAS No.1264-62-6
MDL No.MFCD00084692
MFC43H75NO16
MW862.10
InChI KeyNSYZCCDSJNWWJL-YXOIYICCSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Erythromycin ethylsuccinate is an erythromycin derivative in which the 3R-hydroxy group of erythromycin A is replaced by a (4-ethoxy-4-oxobutanoyl)oxy group. It is used to treat various bacterial infections and is classified as a succinate ester, cyclic ketone, ethyl ester, and erythromycin derivative. It is functionally related to erythromycin A.

CAS No.1264-62-6
Product NameErythromycin ethyl succinate

Associated Conditions

whooping cough·osteomyelitis·type 1 diabetes mellitus·infection·amyotrophic lateral sclerosis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole.

Journal of acquired immune deficiency syndromes • Vol. 4, Issue 5 • 1991
PMID: 2016690

Documentation

Similar Products